U.S. federal trademark · Serial No. 86711505
Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research
Engineered cell therapies for medical purposes, namely, for use in treating cancer
Biochemicals, namely, proteolytically-activatable or protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue; diagnostic and therapeutic kits consisting of proteolytically-activatable or protease-activatable, or proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue; immunoglobulin for drug conjugation and targeted cell binding for laboratory and research use
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.